Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Haleon PLC ( (GB:HLN) ) is now available.
Haleon has published updated listing particulars for its £10 billion Euro Medium Term Note programme, issued through Haleon UK Capital plc and Haleon Netherlands Capital B.V. and guaranteed by the parent company. The routine annual update underpins the group’s access to debt capital markets and supports ongoing financing flexibility for its consumer health operations.
The documentation is now available to investors via Haleon’s website, providing transparency around the terms of the EMTN programme. By maintaining this sizeable funding framework, Haleon reinforces its capacity to support investment in its brand portfolio and preserves financial optionality in a competitive global consumer health sector.
The most recent analyst rating on (GB:HLN) stock is a Buy with a £400.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Spark’s Take on HLN Stock
According to Spark, TipRanks’ AI Analyst, HLN is a Neutral.
The score is driven primarily by solid financial performance (consistent free cash flow and improving profitability) and a cautiously positive earnings outlook supported by margin gains and cost savings. This is tempered by weaker near-term technical momentum and only moderate valuation support.
To see Spark’s full report on HLN stock, click here.
More about Haleon PLC
Haleon plc is a global consumer health company focused on improving everyday health through over-the-counter products. Its portfolio spans oral health, vitamins, minerals and supplements, pain relief, respiratory and digestive health, and therapeutic skin health, with well-known brands such as Advil, Centrum, Panadol, Sensodyne, Theraflu and Voltaren serving more than one billion consumers worldwide.
Average Trading Volume: 22,796,803
Technical Sentiment Signal: Sell
Current Market Cap: £29.71B
For detailed information about HLN stock, go to TipRanks’ Stock Analysis page.